Company Spotlight

Cytovance Biologics

800 Research Pkwy., Suite 200
Oklahoma City, OK 73104
United States
View Profile

Quotient Sciences

3080 McCann Farm Drive
Garnet Valley, PA 19060
United States
View Profile


Contract Service Directory


Eurofins Viracor Biopharma Services





Company Headquarters

1001 Technology Drive,
Lee's Summit, MO 64086
United States

Contract Service Directory

    Related Content

    • A Guide to Vaccine Development from Lubrizol Life Science

      A Guide to Vaccine Development from Lubrizol Life Science

      The current COVID-19 pandemic emphasizes the need for safe and effective vaccines against new pathogens.

    • cGMP Manufacture | Clinical Trials | Drug Development | Information Technology | R&D
      COVID-19’s Long-Term Impact on Drug Development: The New Pragmatism

      COVID-19’s Long-Term Impact on Drug Development: The New Pragmatism

      The rise of new tools and approaches, an increase in regulatory responsibility, and the need for speed.
      Paul Bridges SVP Worldwide Head Regulatory & Access, Parexel and Sheela Hegde, Partner and Managing Director, Health Advances 05.18.20

    • Breaking News | Facilities | Industry News | Inspections
      PharmaCyte Conducts Final Audit of Mfg. Facility

      PharmaCyte Conducts Final Audit of Mfg. Facility

      Batch records in Thailand have been deemed cGMP compliant
      Contract Pharma Staff 05.18.20


    • Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
      Sabin and ReiThera Enter Clinical Manufacturing Pact

      Sabin and ReiThera Enter Clinical Manufacturing Pact

      BARDA provides the Sabin Vaccine Institute with additional $20mn for further development of Ebola Sudan and Marburg vaccines
      Contract Pharma Staff 05.14.20

    • Vetter’s high performance is again recognized at the 2020 CMO Leadership Awards

      A win in all six core categories reaffirms Vetter as a trusted solution provider

    • Quality-by-Design Approach to Manufacturing Cell and Gene Therapies